Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nadine Prinz"'
Autor:
Gerd Gladigau, Philipp Haselmayer, Inge Scharrer, Markus Munder, Nadine Prinz, Karl Lackner, Hansjörg Schild, Pamela Stein, Markus P Radsak
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e42176 (2012)
The anti-phospholipid syndrome (APS) is characterized by recurrent thrombosis and occurrence of anti-phospholipid antibodies (aPL). aPL are necessary, but not sufficient for the clinical manifestations of APS. Growing evidence suggests a role of inna
Externí odkaz:
https://doaj.org/article/2077a1f4c8974df586961238e9f74ec3
Publikováno v:
Thrombosis and Haemostasis. 109:525-531
SummaryAntiphospholipid antibodies (aPL) have been shown to induce tissue factor (TF) expression in monocytes and endothelial cells. However, the underlying signal transduction has been more or less elusive in the past. We have recently shown that aP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b6d63a1f2f1c923fa89cc3c49d46c7
https://doi.org/10.1160/th12-06-0421
https://doi.org/10.1160/th12-06-0421
Autor:
Markus P. Radsak, Karl J. Lackner, Hansjörg Schild, Mareike Lorenz, Inge Pütz, Nadine Prinz, Dennis Strand, Adriana Degreif, Natascha Clemens, Pamela Stein, Philipp von Landenberg, Stefan Bauer, Andreas Daiber
Publikováno v:
Blood. 118:2322-2332
The antiphospholipid syndrome (APS) is an autoimmune disease characterized by thromboembolic events and/or fetal loss in the presence of antiphospholipid antibodies (aPLs). The mechanisms underlying the pathogenicity of aPLs are still poorly understo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43b8ddb0cd9dd05121a0ac9a1fa36df2
https://doi.org/10.1182/blood-2011-01-330639
https://doi.org/10.1182/blood-2011-01-330639
Publikováno v:
Immunobiology. 216:145-151
Antiphospholipid antibodies (aPL) are likely involved in the pathogenesis of the antiphospholipid syndrome (APS). This study analyzes the structural and functional characteristics of a human monoclonal aPL (HL7G) from the IgG2 subtype with λ light c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daface65a152a3ac71c8dde9e303cccf
https://doi.org/10.1016/j.imbio.2010.05.001
https://doi.org/10.1016/j.imbio.2010.05.001
Autor:
Joab Chapman, Philipp von Landenberg, Stefan Bauer, Maik D. Drechsler, Mareike Lorenz, Julia Hurst, Nadine Prinz, Miri Blank, Yehuda Shoenfeld, Natascha Clemens, Yvonne Döring, Karl J. Lackner
Publikováno v:
Immunobiology. 215:230-241
The antiphospholipid syndrome (APS) is characterized by recurrent arterial and/or venous thromboses, pregnancy loss and the presence of antiphospholipid antibodies (aPL). One of the discussed mechanisms of this thrombotic activity in APS patients is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66ba2db70ceb378045a9b4796b4b6af1
https://doi.org/10.1016/j.imbio.2009.03.002
https://doi.org/10.1016/j.imbio.2009.03.002
Publikováno v:
Current Rheumatology Reports. 12:58-63
The antiphospholipid syndrome (APS) is an autoimmune disease characterized by thrombosis, recurrent fetal loss, and the presence of antiphospholipid antibodies (aPL). Recent data support the idea that the thrombotic activity in APS patients is attrib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea55a49010d5ac2ce8336aa3113d254b
https://doi.org/10.1007/s11926-009-0079-0
https://doi.org/10.1007/s11926-009-0079-0
Autor:
Nadine Prinz, Markus Munder, Inge Scharrer, Markus P. Radsak, Pamela Stein, Gerd Gladigau, Philipp Haselmayer, Hansjörg Schild, Karl J. Lackner
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e42176 (2012)
PLoS ONE
PLoS ONE
The anti-phospholipid syndrome (APS) is characterized by recurrent thrombosis and occurrence of anti-phospholipid antibodies (aPL). aPL are necessary, but not sufficient for the clinical manifestations of APS. Growing evidence suggests a role of inna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b57435ba150e1cea72337ca5155d02
http://europepmc.org/articles/PMC3409186?pdf=render
http://europepmc.org/articles/PMC3409186?pdf=render
Autor:
Philipp von Landenberg, Karl J. Lackner, Julia Hurst, Stefan Bauer, Joab Chapman, Mareike Lorenz, Nadine Prinz
Publikováno v:
Immunobiology. 214(8)
TLRs represent the first line of defense against invading pathogens in the innate immune system. Certain cytokines are important mediators and essentially necessary to assure an appropriately regulated immune response. Recent data gave initial eviden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3ba029192fbacc66c64504091fbc243
https://pubmed.ncbi.nlm.nih.gov/19249118
https://pubmed.ncbi.nlm.nih.gov/19249118